William E. Perkins

3.6k total citations · 1 hit paper
38 papers, 1.4k citations indexed

About

William E. Perkins is a scholar working on Pharmacology, Organic Chemistry and Surgery. According to data from OpenAlex, William E. Perkins has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Pharmacology, 12 papers in Organic Chemistry and 7 papers in Surgery. Recurrent topics in William E. Perkins's work include Inflammatory mediators and NSAID effects (15 papers), Synthesis of β-Lactam Compounds (7 papers) and Synthesis and biological activity (5 papers). William E. Perkins is often cited by papers focused on Inflammatory mediators and NSAID effects (15 papers), Synthesis of β-Lactam Compounds (7 papers) and Synthesis and biological activity (5 papers). William E. Perkins collaborates with scholars based in United States, United Kingdom and Canada. William E. Perkins's co-authors include Carol M. Koboldt, Karen Seibert, Jaime L. Masferrer, Ben S. Zweifel, Roland S. Rogers, Matthew J. Graneto, Alexander F. Shaffer, David Brown, John J. Talley and Jeffery S. Carter and has published in prestigious journals such as Journal of Bacteriology, Journal of Applied Physiology and Journal of Medicinal Chemistry.

In The Last Decade

William E. Perkins

37 papers receiving 1.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2

2000 569 citations John J. Talley, David Brown et al. Journal of Medicinal Chemistry profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William E. Perkins United States	16	815	601	248	157	113	38	1.4k
Giichi Goto Japan	19	611 0.7×	395 0.7×	543 2.2×	130 0.8×	34 0.3×	59	2.0k
Yves Girard Canada	26	1.0k 1.3×	355 0.6×	514 2.1×	62 0.4×	41 0.4×	82	2.2k
J. Nita Cogburn United States	10	275 0.3×	220 0.4×	207 0.8×	53 0.3×	54 0.5×	15	611
Christina Weinigel Germany	21	238 0.3×	404 0.7×	314 1.3×	103 0.7×	38 0.3×	29	1.1k
Rajani Giridhar India	26	782 1.0×	276 0.5×	542 2.2×	66 0.4×	300 2.7×	97	1.6k
Katrin Fischer Germany	18	224 0.3×	437 0.7×	493 2.0×	91 0.6×	48 0.4×	36	1.0k
P.M. Woollard United Kingdom	19	276 0.3×	179 0.3×	403 1.6×	45 0.3×	38 0.3×	25	1.2k
Carmela Gnerre Switzerland	18	374 0.5×	254 0.4×	288 1.2×	50 0.3×	81 0.7×	39	1.1k
W. Stephen Faraci United States	18	275 0.3×	299 0.5×	752 3.0×	69 0.4×	26 0.2×	25	1.3k
Bruno Catalanotti Italy	21	415 0.5×	336 0.6×	573 2.3×	35 0.2×	292 2.6×	59	1.4k

Countries citing papers authored by William E. Perkins

Since Specialization

Citations

This map shows the geographic impact of William E. Perkins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William E. Perkins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William E. Perkins more than expected).

Fields of papers citing papers by William E. Perkins

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William E. Perkins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William E. Perkins. The network helps show where William E. Perkins may publish in the future.

Co-authorship network of co-authors of William E. Perkins

This figure shows the co-authorship network connecting the top 25 collaborators of William E. Perkins. A scholar is included among the top collaborators of William E. Perkins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William E. Perkins. William E. Perkins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Talley, John J., David Brown, Jeffery S. Carter, et al.. (2000). 4-[5-Methyl-3-phenylisoxazol-4-yl]- benzenesulfonamide, Valdecoxib: A Potent and Selective Inhibitor of COX-2. Journal of Medicinal Chemistry. 43(5). 775–777. 569 indexed citations breakdown →

Anderson, Graham, Earl G. Burton, J. Nita Cogburn, et al.. (1996). ChemInform Abstract: 1,2‐Diarylcyclopentenes as Selective Cyclooxygenase‐2 Inhibitors and Orally Active anti‐Inflammatory Agents.. ChemInform. 27(10). 4 indexed citations

Gullikson, Gary W., et al.. (1995). Polymeric delivery of the active isomer of misoprostol reduces systemic availability and uterotonic activity.. Journal of Pharmacology and Experimental Therapeutics. 273(3). 1123–1131. 3 indexed citations

Rainsford, K. D., William E. Perkins, & Paul Stetsko. (1995). Chronic effects of misoprostol in combination with the NSAID, diclofenac, on gastrointestinal tract of pigs. Digestive Diseases and Sciences. 40(7). 1435–1444. 9 indexed citations

Reitz, David B., Hechang Huang, Daniel J. Garland, et al.. (1995). ChemInform Abstract: Selective Cyclooxygenase Inhibitors: Novel 4‐Spiro 1,2‐ Diarylcyclopentenes are Potent and Orally Active COX‐2 Inhibitors.. ChemInform. 26(34). 1 indexed citations

Lanthorn, Thomas H., Robert G. Bianchi, & William E. Perkins. (1995). EP1 receptor antagonist blocks the diarrheagenic, but not cytoprotective, actions of a synthetic prostaglandin. Drug Development Research. 34(1). 35–38. 10 indexed citations

Bertenshaw, Stephen R., D. Joseph Rogier, Matthew J. Graneto, et al.. (1995). 3,4-diarylthiophenes are selective COX-2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 5(23). 2919–2922. 1 indexed citations

Tsai, B S, Robert H. Keith, William E. Perkins, et al.. (1995). Preferential binding of the novel prostaglandin SC-46275 to canine gastric versus intestinal receptors.. Journal of Pharmacology and Experimental Therapeutics. 275(1). 368–373. 9 indexed citations

Perkins, William E., Roberto Bianchi, Samuel J. Tremont, et al.. (1994). Polymer delivery of the active isomer of misoprostol: a solution to the intestinal side effect problem.. Journal of Pharmacology and Experimental Therapeutics. 269(1). 151–156. 7 indexed citations

10.

Keith, Robert H., B S Tsai, Paul W. Collins, et al.. (1992). Characterization of prostaglandin E receptors in canine small intestine using [3H] prostaglandin E1 binding. Prostaglandins. 44(6). 579–595. 3 indexed citations

11.

Collins, Paul W., Robert L. Shone, William E. Perkins, et al.. (1992). Synthesis and structure-activity relationships of acyclic .omega. chain conjugated diene analogs of enisoprost. Journal of Medicinal Chemistry. 35(4). 694–704. 4 indexed citations

12.

Collins, Paul W., Robert L. Shone, Alan F. Gasiecki, et al.. (1992). Stabilization of a prostaglandin tertiary allylic alcohol system by fluorine: synthesis, acid stability studies and pharmacology of a 16-fluoromethyl analog of SC-46275.. Bioorganic & Medicinal Chemistry Letters. 2(12). 1761–1766.

13.

Perkins, William E., et al.. (1991). The effect of treatment with 13-cis-retinoic acid on the metabolic burst of peripheral blood neutrophils from patients with acne. British Journal of Dermatology. 124(5). 429–432. 18 indexed citations

14.

Collins, Paul W., Alan F. Gasiecki, William E. Perkins, et al.. (1990). Chemistry and structure-activity relationships of C-17 unsaturated 18-cycloalkyl and cycloalkenyl analogs of enisoprost. Identification of a promising new antiulcer prostaglandin. Journal of Medicinal Chemistry. 33(10). 2784–2793. 10 indexed citations

15.

Collins, Paul W., Alan F. Gasiecki, William E. Perkins, et al.. (1989). 18-Cycloalkyl analogs of enisoprost. Journal of Medicinal Chemistry. 32(5). 1001–1006. 7 indexed citations

16.

Perkins, William E., et al.. (1986). Lack of Effect of Metoclopramide on Cisplatin-Induced Nephrotoxicity in Rats. The Journal of Urology. 135(3). 658–658. 2 indexed citations

17.

Perkins, William E., et al.. (1975). INFLUENCE OF THE z VALUE OF Clostridium botulinum ON THE ACCURACY OF PROCESS CALCULATIONS. Journal of Food Science. 40(6). 1189–1192. 18 indexed citations

18.

Perkins, William E., et al.. (1973). Effects of carbenoxolone sodium on stress‐induced gastric damage in rats. British Journal of Pharmacology. 47(4). 847–849. 5 indexed citations

19.

Perkins, William E.. (1971). Method for studying electrical and mechanical activity of isolated intestine.. Journal of Applied Physiology. 30(5). 768–771. 10 indexed citations

20.

Bohrer, C. Wallace, et al.. (1959). DESTRUCTION OF CLOSTRIDIUM BOTULINUM BY IONIZING RADIATION I. IN NEUTRAL PHOSPHATE AT ROOM AND FREEZING TEMPERATURES ^a, ^b. Journal of Food Science. 24(1). 44–50. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact